Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FYQ01
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,585
Award facts
- Contract value 100% obligated
- $16,584.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $16,584.54, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. The contract was issued by the Defense Logistics Agency under a firm fixed-price arrangement, with an ultimate completion date of September 29, 2025. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and extending through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide.
No set-aside designation was used for this procurement. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal markets. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver diverse pharmaceutical products, including specialty medications and biologics, to military health facilities. The delivery of Entyvio, a specialty pharmaceutical used in the treatment of inflammatory bowel diseases, underscores the company's role in providing specialized therapeutic agents to support the healthcare needs of the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FYQ01?
SPE2DB25FYQ01 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FYQ01 worth?
The government has obligated $16,585 on SPE2DB25FYQ01.
Is contract SPE2DB25FYQ01 an order under another contract?
Yes. SPE2DB25FYQ01 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYQ01 competed?
The extent of competition for SPE2DB25FYQ01 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award